Genocea Biosciences
A biopharmaceutical company developing T cell vaccines and immunotherapies
4
Funding Rounds
$145.3m
Money raised
Overview
A biopharmaceutical company developing T cell vaccines and immunotherapies
-
Website:
- Business model: B2B B2C
- Headquarters: Cambridge, Massachusetts
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** Si* (e** | - | - | - |
| Jo** Wo*** | - | - | linkedin twitter facebook |
| Ke*** Bi** |
|
- | linkedin twitter |
| Ro* Pa*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka Bo**** | - | - | - |
| Ge**** Si*** | - | - | - |
| Mi Hi | - | - | - |
| Je* He**** | - | - | - |
| Al* Be** | - | - | |
| Jo** Lu**** | - | - | |
| Ke Ba** | - | - | - |
| Ch** Cl*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Genocea Biosciences has raised a total of $65.4m in funding over 4 rounds.
Key Insights:
- Genocea Biosciences seed round: $400k
- Genocea Biosciences Series C round: $30m
- Genocea Biosciences Series B round: $35m
- GENOCEA BIOSCIENCES, INC. funding round, July 2020: $79.88m
Genocea Biosciences seed round
$400k
Genocea Biosciences Series C round
$30m
Genocea Biosciences Series B round
$35m
GENOCEA BIOSCIENCES, INC. funding round, July 2020
$79.88m
Industries
Genocea Biosciences is active in the following industries: